Can ADAMTS13 lead us to the paradise of personalized medicine?
Steno Diabetes Center, Gentofte, Denmark.
Peter
P
Rossing
Maria
M
Lajer
D051722:ADAM Proteins / Q000097:blood*; D000071120:ADAMTS13 Protein; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood*; D003928:Diabetic Nephropathies / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide
D000806:Angiotensin-Converting Enzyme Inhibitors; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human